In a study utilizing ovarian cancer cell lines, Jia et al. observed decreased cancer cell proliferation and motility after the addition of FAK inhibitors [52], suggesting that FAK may be involved in tumor growth and migration promotion. This evidence concerns the gene PTK2 and ovarian cancer.